FDA-approved GLP-1 medication that helps you lose 15-20% of your body weight. Medical supervision, personalized protocols, and ongoing support at our Sandy and Layton clinics.
Semaglutide is a groundbreaking GLP-1 receptor agonist medication that has revolutionized medical weight loss. Originally developed for type 2 diabetes (Ozempic), it's now FDA-approved specifically for chronic weight management under the brand name Wegovy.
Unlike diet pills that force temporary appetite suppression, semaglutide works with your body's natural hormonal systems. It mimics GLP-1, a hormone that signals fullness to your brain, slows digestion, and improves how your body handles blood sugar.
Clinical trials show patients lose an average of 15-20% of their body weight—significantly more than diet and exercise alone.
86% of patients achieved clinically significant weight loss of 5% or more of their body weight.
The average patient loses approximately 35 pounds over the course of treatment.
The landmark STEP 1 trial showed sustained weight loss over 68 weeks of treatment.
Free evaluation to assess your health history, weight loss goals, and determine if semaglutide is right for you.
Begin with a low dose (0.25mg) for the first 4 weeks to allow your body to adjust and minimize side effects.
Gradually increase dose every 4 weeks until reaching the therapeutic dose (2.4mg for Wegovy) based on tolerance.
Regular check-ins, nutritional guidance, and protocol adjustments to optimize your results and manage any side effects.
Both Ozempic and Wegovy contain semaglutide, but they're approved for different purposes:
At Mint Medical Clinic, we'll help you determine which formulation and dosing strategy is best for your goals.
Most side effects are mild and temporary, especially with our gradual titration approach.
Nausea, vomiting, diarrhea, constipation, and stomach discomfort are most common when starting or increasing doses. These typically improve within a few weeks.
Gradual dose increases, dietary modifications, timing adjustments, and supportive medications when needed help most patients tolerate treatment well.
Pancreatitis and gallbladder problems are rare but serious. We monitor for warning signs and provide clear guidance on when to seek immediate care.
Semaglutide is a GLP-1 receptor agonist medication that mimics a natural hormone to reduce appetite and increase feelings of fullness. Brand names include Ozempic (for diabetes) and Wegovy (for weight loss). It's administered as a once-weekly injection and is FDA-approved for chronic weight management.
Clinical trials show patients lose an average of 15-20% of their body weight with semaglutide. Results vary based on starting weight, diet, exercise, and individual response. Most patients see significant results within 3-6 months of treatment.
Common side effects include nausea, vomiting, diarrhea, constipation, and stomach pain, especially when starting or increasing doses. These typically improve over time. Gradual dose titration helps minimize side effects. Serious side effects are rare but include pancreatitis and gallbladder problems.
Semaglutide is typically used as a long-term treatment. Most patients maintain treatment for at least 12-24 months. Research shows weight regain often occurs after stopping medication, so ongoing treatment or a maintenance plan is usually recommended.
Insurance coverage for semaglutide varies. Wegovy (weight loss indication) may have limited coverage. We offer affordable self-pay pricing and financing options through LiteCredit to make treatment accessible regardless of insurance status.
Semaglutide is FDA-approved for adults with BMI ≥30 (obesity) or BMI ≥27 with at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol). It's not recommended for those with personal or family history of medullary thyroid cancer or MEN 2 syndrome.
Semaglutide is more effective than previous weight loss medications, producing 15-20% weight loss compared to 5-10% with older drugs. It works on multiple pathways including appetite, satiety, and metabolism. The once-weekly dosing is also more convenient than daily medications.
Schedule your FREE consultation today to learn if semaglutide is right for you. No obligation, personalized guidance.
Financing available through LiteCredit